monoclonal antibody (University of Barcelona/Fundació BOSCH I GIMPERA)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemonoclonal antibody (University of Barcelona/Fundació BOSCH I GIMPERA)

Drug Alias NameMonoclonal Antibody Targeting Substance P (University of Barcelona/Fundació BOSCH I GIMPERA)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulatorsEpidermal growth factor receptor erbB1 modulatorsNeurokinin 1 receptor antagonists

TargetsEpidermal growth factor receptor erbB1Receptor protein-tyrosine kinase erbB-2Neurokinin 1 receptor

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversitat De Barcelona

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversitat De Barcelona

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A